Това може също така да се наблюдава и при други кортикостероиди, които се метаболизират посредством P450 3A, например будезонид.
Systemic corticosteroid effects including Cushing's syndrome and adrenal suppression have been reported in patients receiving ritonavir and inhaled or intranasally administered fluticasone propionate; this could also occur with other corticosteroids metabolised via the P450 3A pathway e.g. budesonide.